UK markets close in 5 hours 5 minutes

Sorrento Therapeutics, Inc. (0L85.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
0.0150-0.0092 (-38.02%)
As of 02:34PM BST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.82
52-week change 3-82.43%
S&P500 52-week change 323.23%
52-week high 30.4046
52-week low 30.0000
50-day moving average 30.0635
200-day moving average 30.2123

Share statistics

Avg vol (3-month) 3466.06k
Avg vol (10-day) 3666.79k
Shares outstanding 5111.3M
Implied shares outstanding 6N/A
Float 8538.99M
% held by insiders 10.89%
% held by institutions 10.64%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Jun 2023


Profit margin 0.00%
Operating margin (ttm)-510.93%

Management effectiveness

Return on assets (ttm)-40.81%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)64.27M
Revenue per share (ttm)0.13
Quarterly revenue growth (yoy)31.10%
Gross profit (ttm)N/A
EBITDA -341.59M
Net income avi to common (ttm)-548M
Diluted EPS (ttm)-1.5270
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)80.64M
Total cash per share (mrq)0.15
Total debt (mrq)207.6M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.41
Book value per share (mrq)-0.38

Cash flow statement

Operating cash flow (ttm)-234.63M
Levered free cash flow (ttm)-57.53M